Indaptus Therapeutics Ownership 2024 | Who Owns Indaptus Therapeutics Now?
Institutional Ownership
3.29%
Insider Ownership
26.67%
Retail Ownership
70.03%
Institutional Holders
6.00
Indaptus Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
VANGUARD GROUP INC | 3.04% | - | 256,265 | - | - | 543,282 | Jun 30, 2024 |
INVESTMENT HOUSE LLC | 1.21% | 0.01% | 102,437 | - | - | 217,166 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.70% | - | 59,309 | 4,542 | 8.29% | 125,755 | Jun 30, 2024 |
STRATEGY ASSET MANAGERS LLC | 0.54% | 0.02% | 45,336 | - | - | 86,592 | Jun 30, 2024 |
PINE VALLEY INVESTMENTS LTD LIABILITY CO | 0.52% | 0.01% | 44,085 | -60 | -0.14% | 93,461 | Jun 30, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 0.32% | 0.00% | 26,600 | 500 | 1.92% | 56,392 | Jun 30, 2024 |
VIVALDI CAPITAL MANAGEMENT LP | 0.28% | 0.01% | 24,000 | - | - | 50,880 | Jun 30, 2024 |
STATE STREET CORP | 0.15% | - | 13,073 | - | - | 27,715,000 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.05% | 0.00% | 4,102 | 36 | 0.89% | 8,696 | Jun 30, 2024 |
MORGAN STANLEY | 0.01% | - | 884 | - | - | 1,874 | Jun 30, 2024 |
UBS GROUP AG | 0.01% | - | 692 | -1,244 | -64.26% | 1,467 | Jun 30, 2024 |
BANGOR SAVINGS BANK | 0.00% | 0.00% | 400 | - | - | 848 | Jun 30, 2024 |
BEAIRD HARRIS WEALTH MANAGEMENT, LLC | 0.00% | 0.00% | 300 | 300 | 100.00% | 636 | Jun 30, 2024 |
FMR LLC | 0.00% | - | 79 | 79 | 100.00% | 167 | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | 0.00% | - | 64 | -41 | -39.05% | 136 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 42 | 42 | 100.00% | 89 | Jun 30, 2024 |
JPMORGAN CHASE & CO | 0.00% | - | 15 | 1 | 7.14% | 32 | Jun 30, 2024 |
GROUP ONE TRADING, L.P. | 0.00% | - | 7 | - | - | 15,000 | Jun 30, 2024 |
QUBE RESEARCH & TECHNOLOGIES LTD | - | - | 1 | - | - | 2 | Jun 30, 2024 |
VIRTU FINANCIAL LLC | - | - | - | -14,232 | -100.00% | - | Jun 30, 2024 |
Indaptus Therapeutics's largest institutional shareholder is VANGUARD GROUP INC, holding 3.04% of the company's total share outstanding, currently valued at $543.28K. The top 10 institutional shareholders own together 6.82% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
STRATEGY ASSET MANAGERS LLC | 0.54% | 0.02% | 45,336 | - | - | 86,592 | Jun 30, 2024 |
VIVALDI CAPITAL MANAGEMENT LP | 0.28% | 0.01% | 24,000 | - | - | 50,880 | Jun 30, 2024 |
INVESTMENT HOUSE LLC | 1.21% | 0.01% | 102,437 | - | - | 217,166 | Jun 30, 2024 |
PINE VALLEY INVESTMENTS LTD LIABILITY CO | 0.52% | 0.01% | 44,085 | -60 | -0.14% | 93,461 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.05% | 0.00% | 4,102 | 36 | 0.89% | 8,696 | Jun 30, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 0.32% | 0.00% | 26,600 | 500 | 1.92% | 56,392 | Jun 30, 2024 |
BANGOR SAVINGS BANK | 0.00% | 0.00% | 400 | - | - | 848 | Jun 30, 2024 |
BEAIRD HARRIS WEALTH MANAGEMENT, LLC | 0.00% | 0.00% | 300 | 300 | 100.00% | 636 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.70% | - | 59,309 | 4,542 | 8.29% | 125,755 | Jun 30, 2024 |
VANGUARD GROUP INC | 3.04% | - | 256,265 | - | - | 543,282 | Jun 30, 2024 |
STATE STREET CORP | 0.15% | - | 13,073 | - | - | 27,715,000 | Jun 30, 2024 |
UBS GROUP AG | 0.01% | - | 692 | -1,244 | -64.26% | 1,467 | Jun 30, 2024 |
MORGAN STANLEY | 0.01% | - | 884 | - | - | 1,874 | Jun 30, 2024 |
GROUP ONE TRADING, L.P. | 0.00% | - | 7 | - | - | 15,000 | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | 0.00% | - | 64 | -41 | -39.05% | 136 | Jun 30, 2024 |
FMR LLC | 0.00% | - | 79 | 79 | 100.00% | 167 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 42 | 42 | 100.00% | 89 | Jun 30, 2024 |
QUBE RESEARCH & TECHNOLOGIES LTD | - | - | 1 | - | - | 2 | Jun 30, 2024 |
JPMORGAN CHASE & CO | 0.00% | - | 15 | 1 | 7.14% | 32 | Jun 30, 2024 |
VIRTU FINANCIAL LLC | - | - | - | -14,232 | -100.00% | - | Jun 30, 2024 |
The largest Indaptus Therapeutics shareholder by % of total assets is STRATEGY ASSET MANAGERS LLC. The company owns 45.34K shares of Indaptus Therapeutics (INDP), representing 0.02% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
GEODE CAPITAL MANAGEMENT, LLC | 0.70% | - | 59,309 | 4,542 | 8.29% | 125,755 | Jun 30, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 0.32% | 0.00% | 26,600 | 500 | 1.92% | 56,392 | Jun 30, 2024 |
BEAIRD HARRIS WEALTH MANAGEMENT, LLC | 0.00% | 0.00% | 300 | 300 | 100.00% | 636 | Jun 30, 2024 |
FMR LLC | 0.00% | - | 79 | 79 | 100.00% | 167 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 42 | 42 | 100.00% | 89 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.05% | 0.00% | 4,102 | 36 | 0.89% | 8,696 | Jun 30, 2024 |
JPMORGAN CHASE & CO | 0.00% | - | 15 | 1 | 7.14% | 32 | Jun 30, 2024 |
QUBE RESEARCH & TECHNOLOGIES LTD | - | - | 1 | - | - | 2 | Jun 30, 2024 |
GROUP ONE TRADING, L.P. | 0.00% | - | 7 | - | - | 15,000 | Jun 30, 2024 |
MORGAN STANLEY | 0.01% | - | 884 | - | - | 1,874 | Jun 30, 2024 |
STATE STREET CORP | 0.15% | - | 13,073 | - | - | 27,715,000 | Jun 30, 2024 |
VANGUARD GROUP INC | 3.04% | - | 256,265 | - | - | 543,282 | Jun 30, 2024 |
BANGOR SAVINGS BANK | 0.00% | 0.00% | 400 | - | - | 848 | Jun 30, 2024 |
INVESTMENT HOUSE LLC | 1.21% | 0.01% | 102,437 | - | - | 217,166 | Jun 30, 2024 |
VIVALDI CAPITAL MANAGEMENT LP | 0.28% | 0.01% | 24,000 | - | - | 50,880 | Jun 30, 2024 |
STRATEGY ASSET MANAGERS LLC | 0.54% | 0.02% | 45,336 | - | - | 86,592 | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | 0.00% | - | 64 | -41 | -39.05% | 136 | Jun 30, 2024 |
PINE VALLEY INVESTMENTS LTD LIABILITY CO | 0.52% | 0.01% | 44,085 | -60 | -0.14% | 93,461 | Jun 30, 2024 |
UBS GROUP AG | 0.01% | - | 692 | -1,244 | -64.26% | 1,467 | Jun 30, 2024 |
VIRTU FINANCIAL LLC | - | - | - | -14,232 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Indaptus Therapeutics's largest institutional buyer is GEODE CAPITAL MANAGEMENT, LLC. The company purchased 4.54K stocks of INDP, valued at $125.75K.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
VIRTU FINANCIAL LLC | - | - | - | -14,232 | -100.00% | - | Jun 30, 2024 |
UBS GROUP AG | 0.01% | - | 692 | -1,244 | -64.26% | 1,467 | Jun 30, 2024 |
PINE VALLEY INVESTMENTS LTD LIABILITY CO | 0.52% | 0.01% | 44,085 | -60 | -0.14% | 93,461 | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | 0.00% | - | 64 | -41 | -39.05% | 136 | Jun 30, 2024 |
STRATEGY ASSET MANAGERS LLC | 0.54% | 0.02% | 45,336 | - | - | 86,592 | Jun 30, 2024 |
VIVALDI CAPITAL MANAGEMENT LP | 0.28% | 0.01% | 24,000 | - | - | 50,880 | Jun 30, 2024 |
INVESTMENT HOUSE LLC | 1.21% | 0.01% | 102,437 | - | - | 217,166 | Jun 30, 2024 |
BANGOR SAVINGS BANK | 0.00% | 0.00% | 400 | - | - | 848 | Jun 30, 2024 |
VANGUARD GROUP INC | 3.04% | - | 256,265 | - | - | 543,282 | Jun 30, 2024 |
STATE STREET CORP | 0.15% | - | 13,073 | - | - | 27,715,000 | Jun 30, 2024 |
MORGAN STANLEY | 0.01% | - | 884 | - | - | 1,874 | Jun 30, 2024 |
GROUP ONE TRADING, L.P. | 0.00% | - | 7 | - | - | 15,000 | Jun 30, 2024 |
QUBE RESEARCH & TECHNOLOGIES LTD | - | - | 1 | - | - | 2 | Jun 30, 2024 |
JPMORGAN CHASE & CO | 0.00% | - | 15 | 1 | 7.14% | 32 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.05% | 0.00% | 4,102 | 36 | 0.89% | 8,696 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 42 | 42 | 100.00% | 89 | Jun 30, 2024 |
FMR LLC | 0.00% | - | 79 | 79 | 100.00% | 167 | Jun 30, 2024 |
BEAIRD HARRIS WEALTH MANAGEMENT, LLC | 0.00% | 0.00% | 300 | 300 | 100.00% | 636 | Jun 30, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 0.32% | 0.00% | 26,600 | 500 | 1.92% | 56,392 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.70% | - | 59,309 | 4,542 | 8.29% | 125,755 | Jun 30, 2024 |
As of Jun 30 2024, Indaptus Therapeutics's biggest institutional seller is VIRTU FINANCIAL LLC. The company sold -14.23K shares of INDP, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
BEAIRD HARRIS WEALTH MANAGEMENT, LLC | 0.00% | 0.00% | 300 | 300 | 100.00% | 636 | Jun 30, 2024 |
FMR LLC | 0.00% | - | 79 | 79 | 100.00% | 167 | Jun 30, 2024 |
Indaptus Therapeutics's largest new institutional shareholder by number of shares is BEAIRD HARRIS WEALTH MANAGEMENT, LLC, purchased 300.00 shares, valued at $636.00, as of undefined.
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
VIRTU FINANCIAL LLC | - | - | - | -14,232 | -100.00% | - | Jun 30, 2024 |
Indaptus Therapeutics's largest sold out institutional shareholder by shares sold is VIRTU FINANCIAL LLC, sold -14.23K shares, valued at -, as of undefined.
Indaptus Therapeutics Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
FIDELITY COMMONWEALTH TRUST | 0.02% | 61,459 | - | - | Feb 29, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 256,265 | -27,068 | -9.55% | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 51,433 | -207 | -0.40% | Feb 29, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 765 | - | - | Jan 31, 2024 |
JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 527 | - | - | Mar 31, 2024 |
Indaptus Therapeutics's largest mutual fund holder by % of total assets is "FIDELITY COMMONWEALTH TRUST", owning 61.46K shares, compromising 0.02% of its total assets.
Indaptus Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Jun, 24 | 6 | -64.71% |
31 Mar, 24 | 17 | -5.56% |
31 Dec, 23 | 18 | 12.50% |
30 Sep, 23 | 16 | 6.67% |
30 Jun, 23 | 15 | - |
31 Mar, 23 | 15 | -6.25% |
31 Dec, 22 | 16 | 23.08% |
30 Sep, 22 | 13 | 8.33% |
30 Jun, 22 | 12 | 9.09% |
31 Mar, 22 | 11 | - |
31 Dec, 21 | 11 | 22.22% |
30 Sep, 21 | 9 | - |
As of 30 Jun 24, 6 institutions are holding Indaptus Therapeutics's shares, representing a decrease of -64.71% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Jun, 24 | 278,167 | -52.67% |
31 Mar, 24 | 587,768 | -2.40% |
31 Dec, 23 | 602,239 | 5.56% |
30 Sep, 23 | 570,529 | -2.26% |
30 Jun, 23 | 583,740 | 0.76% |
31 Mar, 23 | 579,339 | 0.51% |
31 Dec, 22 | 576,419 | 1.68% |
30 Sep, 22 | 566,898 | 13.18% |
30 Jun, 22 | 500,887 | -70.75% |
31 Mar, 22 | 1,712,376 | -6.75% |
31 Dec, 21 | 1,836,293 | 239.12% |
30 Sep, 21 | 541,486 | - |
Indaptus Therapeutics (INDP) has 278.17K shares outstanding as of 30 Jun 24, down -52.67% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Jun, 24 | 3.29% | 6.73% |
31 Mar, 24 | 7.00% | 13.61% |
31 Dec, 23 | 7.17% | 15.54% |
30 Sep, 23 | 6.79% | 14.07% |
30 Jun, 23 | 6.95% | 14.61% |
31 Mar, 23 | 6.90% | 14.17% |
31 Dec, 22 | 6.98% | 14.81% |
30 Sep, 22 | 6.86% | 18.66% |
30 Jun, 22 | 6.07% | 1.41% |
31 Mar, 22 | 20.73% | 4.19% |
31 Dec, 21 | 22.23% | 13.25% |
30 Sep, 21 | 12.95% | - |
As of 30 Jun 24, Indaptus Therapeutics is held by 3.29% institutional shareholders, representing a 6.73% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Jun, 24 | 2 | -33.33% |
31 Mar, 24 | 3 | -62.50% |
31 Dec, 23 | 8 | 14.29% |
30 Sep, 23 | 7 | 75.00% |
30 Jun, 23 | 4 | -33.33% |
31 Mar, 23 | 6 | - |
31 Dec, 22 | 6 | - |
30 Sep, 22 | 6 | 50.00% |
30 Jun, 22 | 4 | -20.00% |
31 Mar, 22 | 5 | -44.44% |
31 Dec, 21 | 9 | - |
30 Sep, 21 | 9 | - |
2 institutional shareholders have increased their position in INDP stock as of 30 Jun 24 compared to 3 in the previous quarter (a -33.33% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Jun, 24 | 1 | -80.00% |
31 Mar, 24 | 5 | 150.00% |
31 Dec, 23 | 2 | -50.00% |
30 Sep, 23 | 4 | 100.00% |
30 Jun, 23 | 2 | 100.00% |
31 Mar, 23 | 1 | -66.67% |
31 Dec, 22 | 3 | 50.00% |
30 Sep, 22 | 2 | -33.33% |
30 Jun, 22 | 3 | 50.00% |
31 Mar, 22 | 2 | 100.00% |
31 Dec, 21 | 1 | - |
30 Sep, 21 | - | - |
1 institutional shareholders have reduced their position in INDP stock as of 30 Jun 24 compared to 5 in the previous quarter (a -80.00% decrease).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Jun, 24 | 6 | -64.71% | 278,167 | -52.67% | 3.29% | 6.73% | 2 | -33.33% | 1 | -80.00% |
31 Mar, 24 | 17 | -5.56% | 587,768 | -2.40% | 7.00% | 13.61% | 3 | -62.50% | 5 | 150.00% |
31 Dec, 23 | 18 | 12.50% | 602,239 | 5.56% | 7.17% | 15.54% | 8 | 14.29% | 2 | -50.00% |
30 Sep, 23 | 16 | 6.67% | 570,529 | -2.26% | 6.79% | 14.07% | 7 | 75.00% | 4 | 100.00% |
30 Jun, 23 | 15 | - | 583,740 | 0.76% | 6.95% | 14.61% | 4 | -33.33% | 2 | 100.00% |
31 Mar, 23 | 15 | -6.25% | 579,339 | 0.51% | 6.90% | 14.17% | 6 | - | 1 | -66.67% |
31 Dec, 22 | 16 | 23.08% | 576,419 | 1.68% | 6.98% | 14.81% | 6 | - | 3 | 50.00% |
30 Sep, 22 | 13 | 8.33% | 566,898 | 13.18% | 6.86% | 18.66% | 6 | 50.00% | 2 | -33.33% |
30 Jun, 22 | 12 | 9.09% | 500,887 | -70.75% | 6.07% | 1.41% | 4 | -20.00% | 3 | 50.00% |
31 Mar, 22 | 11 | - | 1,712,376 | -6.75% | 20.73% | 4.19% | 5 | -44.44% | 2 | 100.00% |
31 Dec, 21 | 11 | 22.22% | 1,836,293 | 239.12% | 22.23% | 13.25% | 9 | - | 1 | - |
30 Sep, 21 | 9 | - | 541,486 | - | 12.95% | - | 9 | - | - | - |
Indaptus Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
All Insider Owners Trades
The last insider buy of INDP was made by Anderson Glen R. on Aug 16 2023, buying 23,934 shares at $2.34 per share (worth $56.01K).
Indaptus Therapeutics Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | 2 | - | - |
Q2 2024 | 6 | - | - |
Q1 2024 | 5 | - | - |
Q3 2023 | 4 | - | - |
Q2 2023 | 5 | - | - |
Q1 2023 | 5 | - | - |
Q4 2022 | 4 | - | - |
Q3 2022 | 9 | - | - |
Q2 2022 | 1 | 1 | 100.00% |
Q1 2022 | 7 | 2 | 350.00% |
Q4 2021 | 2 | - | - |
Q3 2021 | 11 | 34 | 32.35% |
2 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Indaptus Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | - | - | - |
Q2 2024 | - | - | - |
Q1 2024 | - | - | - |
Q3 2023 | 3 | - | - |
Q2 2023 | - | - | - |
Q1 2023 | - | - | - |
Q4 2022 | 4 | - | - |
Q3 2022 | 3 | - | - |
Q2 2022 | 1 | - | - |
Q1 2022 | 2 | 2 | 100.00% |
Q4 2021 | 1 | - | - |
Q3 2021 | 1 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Indaptus Therapeutics's stocks.
Indaptus Therapeutics Peer Ownership
Ticker | Company |
---|---|
NTRB | Nutriband Inc. |
MTCR | Metacrine, Inc. |
BWV | Onconetix, Inc. |
ABVC | ABVC BioPharma, Inc. |
KPRX | Kiora Pharmaceuticals, Inc. |
KTTA | Pasithea Therapeutics Corp. |
LGVN | Longeveron Inc. |
REVB | Revelation Biosciences, Inc. |
QNRX | Quoin Pharmaceuticals, Ltd. |
HILS | Tharimmune, Inc. |
VRAX | Virax Biolabs Group Limited |
ASMB | Assembly Biosciences, Inc. |
RNXT | RenovoRx, Inc. |
RZLT | Rezolute, Inc. |
TPST | Tempest Therapeutics, Inc. |
ANEB | Anebulo Pharmaceuticals, Inc. |
FBRX | Forte Biosciences, Inc. |
INDP Ownership FAQ
Who Owns Indaptus Therapeutics?
Indaptus Therapeutics is owned by institutional shareholders (3.29%), insiders (26.67%), and public (70.03%). The largest institutional shareholder of Indaptus Therapeutics is VANGUARD GROUP INC (3.04% of total shares) and the top mutual fund owner is FIDELITY COMMONWEALTH TRUST (0.02% of total shares).
Who are the major institutional shareholders of Indaptus Therapeutics?
Indaptus Therapeutics's major institutional shareholders are VANGUARD GROUP INC, INVESTMENT HOUSE LLC, GEODE CAPITAL MANAGEMENT, LLC, STRATEGY ASSET MANAGERS LLC, and PINE VALLEY INVESTMENTS LTD LIABILITY CO. The top five shareholders own together 6.01% of the company's share outstanding.
How many Indaptus Therapeutics shareholders are there?
As of Jun 2024, there are 6 institutional shareholders of Indaptus Therapeutics.
What percentage of Indaptus Therapeutics is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC owns 256.26K shares of Indaptus Therapeutics, representing 3.04% of the company's total shares outstanding, valued at $543.28K (as of Jun 2024).
What percentage of Indaptus Therapeutics is owned by INVESTMENT HOUSE LLC?
As of Jun 2024, INVESTMENT HOUSE LLC holds 102.44K shares of Indaptus Therapeutics (INDP), compromising 1.21% of the company, valued at $217.17K.
What percentage of Indaptus Therapeutics is owned by GEODE CAPITAL MANAGEMENT, LLC?
GEODE CAPITAL MANAGEMENT, LLC is the third largest holder of Indaptus Therapeutics. The company owns 59.31K of the company's shares outstanding (worth $125.76K).